Must Reads: Scoop Up These Discounted Giants for Explosive Long-Term Gains

Seizing the Market Dip: Why Novo Nordisk and Netflix Are Must-Buy Opportunities in Today’s Volatility

In partnership with

Welcome, Investors!

The market’s been moody lately—one minute it’s surging, the next it’s stalling.
But I’ve learned something over the years: when the market takes a breather, that’s when opportunity knocks.

While fear sends some investors running for the sidelines, I’m doing the opposite. I’m scanning the landscape for undervalued titans—companies with solid fundamentals, global scale, and long-term growth stories that just need a little patience to shine.

In this newsletter, I’m breaking down:

📊 Novo Nordisk: A $280B Powerhouse Trading at a Massive Discount
This healthcare giant is down nearly 60% from its highs—yet analysts see a potential 90% upside. With blockbuster drugs, global reach, and a pipeline built for the future, this isn’t a falling knife—it’s a slingshot.

💰 Netflix: Still Winning the Streaming Wars
While competitors scramble, Netflix keeps doing what it does best—growing. A global subscriber base, surging free cash flow, and ambitious ad revenue targets make this a long-term winner hiding in plain sight.

🏛️ Resilient Financials & Global Reach
From Novo’s industry-leading cash flow margins to Netflix’s 31.7% operating margin, these companies aren’t just hyped—they’re built to last. And with exposure to emerging markets, they’re not limited by borders.

📉 Volatility ≠ Risk, If You Know What You’re Holding
These stocks aren’t immune to headlines or short-term dips—but their fundamentals scream strength. If you’re tired of chasing hype, these are the kinds of opportunities worth holding through the noise.

This isn’t just value investing—it’s smart investing. It’s about separating short-term sentiment from long-term substance. And right now, that substance is selling at a serious discount.

Erwin Dwight

Founder of Investing Wise Academy

FREE CONTENT

Scoop Up These Discounted Giants for Explosive Long-Term Gains

Market pullbacks can feel like chaos, but for savvy investors, they’re a goldmine of opportunity. Enter Novo Nordisk $NVO ( ▲ 4.06% ) and Netflix $NFLX ( ▲ 1.37% ) —two global titans trading at steep discounts despite rock-solid . . .

SPONSOR

Unwind Naturally with Enhanced Relief Gummies

Feel the calm set in with these Enhanced Relief Gummies—crafted with 5mg THC + 75mg CBD for stress relief, reduced anxiety, and deep relaxation without the hangover.

Perfect for evenings when you need to truly unwind. Get 25% off your first order with code RLX25 and experience why this brand has over 48k 5-star reviews.

FEATURED CONTENT

NFLX Q1: Management Emphasizes Content Investments and Ad Platform Expansion

Read The Daily Upside. Stay Ahead of the Markets. Invest Smarter.

Most financial news is full of noise. The Daily Upside delivers real insights—clear, concise, and free. No clickbait, no fear-mongering. Just expert analysis that helps you make smarter investing decisions.

Streaming video giant Netflix $NFLX ( ▲ 1.37% ) met Wall Street’s Q1 CY2025 revenue expectations, with sales rising 12.5% year on year to $10.54 billion. The company projects next quarter’s revenue around $11.04 billion, aligning with analysts’ estimates.

Is now the time to buy NFLX?

TOP MARKET NEWS

Wall Street's iconic charging bull statue vandalized by climate activists wielding neon green paint

April 22, 2025

The climate activist group called Extinction Rebellion painted the words "Greed=Death" on the bull, the symbol of a surging stock market.

About half of Americans have a negative view on Tesla and Elon Musk, CNBC survey finds

April 22, 2025

The broad public and investors have something in common these days: They don't have a lot of love for either Tesla or CEO Elon Musk.

TG Therapeutics: Considering If The Promise Of Accelerated Revenue Growth Is Enough

April 23, 2025

VEA: Solution To A Falling Dollar, Record Alpha And Compelling Valuation

April 23, 2025

TRENDING STOCKS

Stocktwits Logo

Top Gainers

Date (NY Time): 22:28 Tuesday, April 22, 2025 (EDT)

  1. GELS - Gelteq Ltd. - Chart & Analysis from Stocktwits
  2. SXTC - China SXT Pharmaceuticals Inc. - Chart & Analysis from Stocktwits
  3. TIVC - Tivic Health Systems Inc. - Chart & Analysis from Stocktwits

Disclaimer: This information is for educational purposes only. Trading involves risk. Please do your own research. Stocktwits discussions are user-generated and may not reflect accurate financial analysis.

Top Gainer Spotlight

Gelteq Ltd. (GELS) is the top gainer.

Date (NY Time): 22:28 Tuesday, April 22, 2025 (EDT)

Note: Discussions on X are for informational purposes only and should not be considered financial advice. Always conduct your own research.

PREMIUM CONTENT

Get the blueprint to build a winning portfolio today!

Get hold of a profitable portfolio and learn how to trade effortlessly! Applovin and Sea Ltd's stocks demonstrate that this portfolio is already profitable…

PROMO CONTENT

Can email newsletters make money?

With the world becoming increasingly digital, this question will be on the minds of millions of people looking for new income streams in 2025.

The answer is—Absolutely!

That’s it for this episode!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every day. 

 What do you think of the new format? Please provide your feedback in the poll below, and if you find the newsletter valuable, feel free to share it with other investors!

How would you rate today's newsletter?

If you vote 1 or 3 stars, please comment with what you didn't like so we can improve it.

Login or Subscribe to participate in polls.

Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a financial advisor before making any investment decisions.

Reply

or to participate.